Brisbane Newswire

Comprehensive Real-Time News Feed for Brisbane, CA.

Results 1 - 5 of 5 for "u:bloomberg.com" in Brisbane, CA

  1. Nestle Pays $145 Million for Stake in Biotech Firm AimmuneRead the original story

    Nov 6, 2016 | The Washington Post

    Nestle SA's health unit is investing $145 million for a 15 percent stake in Aimmune Therapeutics Inc., a California maker of food-allergy therapies. Nestle Health Science, a subsidiary of the Swiss food giant, will pay $19.20 a share for about 7.55 million newly issued shares of Aimmune, and the unit's Chief Executive Officer Greg Behar will join the biotech firm's board of directors, Aimmune said Friday in a statement.

    Comment?

  2. Nestle Pays $145 Million for Stake in Biotech Firm AimmuneRead the original story

    Nov 6, 2016 | The Washington Post

    Nestle SA's health unit is investing $145 million for a 15 percent stake in Aimmune Therapeutics Inc., a California maker of food-allergy therapies. Nestle Health Science, a subsidiary of the Swiss food giant, will pay $19.20 a share for about 7.55 million newly issued shares of Aimmune, and the unit's Chief Executive Officer Greg Behar will join the biotech firm's board of directors, Aimmune said Friday in a statement.

    Comment?

  3. Mode Media Said to Shut Operations at Once-Hot Lifestyle StartupRead the original story

    Sep 19, 2016 | The Washington Post

    Five years ago, Glam Media was planning an initial public offering that was set to deliver a big payday for its venture capital backers. That never panned out, and the lifestyle media startup, since renamed Mode Media Corp., told employees Thursday that it is shutting down operations, said people familiar with the matter.

    Comment?

  4. KaloBios in Agreement to Buy Former CEO Shkreli's SharesRead the original story

    Jul 9, 2016 | The Washington Post

    KaloBios Pharmaceuticals Inc. said it has an agreement with Martin Shkreli, the company's former chief executive officer who came under fire for raising drug prices, to buy back his shares and restrict his shareholder actions, in a move to cut ties with the controversial investor. The agreement applies to all common stock Shkreli holds or controls in the company, and bars him from nominating board members, Brisbane, California-based KaloBios said Thursday in a statement.

    Comment?

  5. KaloBios in Agreement to Buy Former CEO Shkreli's SharesRead the original story

    Jul 8, 2016 | The Washington Post

    KaloBios Pharmaceuticals Inc. said it has an agreement with Martin Shkreli, the company's former chief executive officer who came under fire for raising drug prices, to buy back his shares and restrict his shareholder actions, in a move to cut ties with the controversial investor. The agreement applies to all common stock Shkreli holds or controls in the company, and bars him from nominating board members, Brisbane, California-based KaloBios said Thursday in a statement.

    Comment?

Brisbane Job Listings
View or post Brisbane job listings on Topix.
Brisbane Real Estate
News, listings, and foreclosures in Brisbane from Topix.
Brisbane Mortgages
Find mortgage rates in Brisbane on Topix.